Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-05-05

Clinical Trial Update: Preventing Alcohol Withdrawal With Oral Baclofen [Phase 2]

View source ↗

Summary

Phase 2 trial evaluated whether oral baclofen could prevent alcohol withdrawal in individuals with alcohol use disorder; the study was terminated and results we…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BACLOFEN (Baclofen)

Snippet

Sponsor: Essentia Health | Conditions: Alcoholism, Alcohol Withdrawal | Phase 2 | Status: TERMINATED | Results posted: 2017-05-05